Követés
György Paragh
György Paragh
University of Debrecen, Medical and Health Science Centre
E-mail megerősítve itt: internal.med.unideb.hu
Cím
Hivatkozott rá
Hivatkozott rá
Év
The impact of obesity on the cardiovascular system
I Csige, D Ujvárosy, Z Szabó, I Lőrincz, G Paragh, M Harangi, S Somodi
Journal of diabetes research 2018 (1), 3407306, 2018
6012018
Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel
AFG Cicero, A Colletti, G Bajraktari, O Descamps, DM Djuric, M Ezhov, ...
Nutrition reviews 75 (9), 731-767, 2017
5402017
The role of nutraceuticals in statin intolerant patients
M Banach, AM Patti, RV Giglio, AFG Cicero, AG Atanasov, G Bajraktari, ...
Journal of the American College of Cardiology 72 (1), 96-118, 2018
2742018
Study of factors influencing the decreased HDL associated PON1 activity with aging
I Seres, G Paragh, E Deschene, T Fulop Jr, A Khalil
Experimental gerontology 39 (1), 59-66, 2004
2722004
Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: a multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunity.
G Kerekes, Z Szekanecz, H Dér, Z Sándor, G Lakos, L Muszbek, I Csipö, ...
The Journal of rheumatology 35 (3), 398-406, 2008
2562008
Rheumatoid arthritis and metabolic syndrome
G Kerekes, MT Nurmohamed, MA Gonzalez-Gay, I Seres, G Paragh, ...
Nature Reviews Rheumatology 10 (11), 691-696, 2014
2402014
Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)
AJ Vallejo-Vaz, CAT Stevens, ARM Lyons, KI Dharmayat, T Freiberger, ...
The Lancet 398 (10312), 1713-1725, 2021
2082021
Overview of the current status of familial hypercholesterolaemia care in over 60 countries-The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)
AJ Vallejo-Vaz, M De Marco, CAT Stevens, A Akram, T Freiberger, ...
Atherosclerosis 277, 234-255, 2018
2032018
Angiogenesis in rheumatoid arthritis
Z Szekanecz, T Besenyei, G Paragh, AE Koch
Autoimmunity 42 (7), 563-573, 2009
1742009
Serum paraoxonase activity changes in patients with Alzheimer's disease and vascular dementia
G Paragh, P Balla, E Katona, I Seres, A Égerházi, I Degrell
European archives of psychiatry and clinical neuroscience 252, 63-67, 2002
1692002
Influence of iron on bone homeostasis
E Balogh, G Paragh, V Jeney
Pharmaceuticals 11 (4), 107, 2018
1572018
Assessment of subclinical vascular disease associated with ankylosing spondylitis
N Bodnár, G Kerekes, I Seres, G Paragh, J Kappelmayer, ZG Némethné, ...
The Journal of Rheumatology 38 (4), 723-729, 2011
1452011
The serum paraoxonase activity in patients with chronic renal failure and hyperlipidemia
G Paragh, I Seres, Z Balogh, Z Varga, I Kárpáti, J Mátyus, L Újhelyi, ...
Nephron 80 (2), 166-170, 1998
1401998
Photodynamic therapy and pain: A systematic review
JM Ang, IB Riaz, MU Kamal, G Paragh, NC Zeitouni
Photodiagnosis and photodynamic therapy 19, 308-344, 2017
1382017
Ultrarestrictive opioid prescription protocol for pain management after gynecologic and abdominal surgery
J Mark, DM Argentieri, CA Gutierrez, K Morrell, K Eng, AD Hutson, ...
JAMA network open 1 (8), e185452-e185452, 2018
1242018
Serum paraoxonase activity changes in uremic and kidney-transplanted patients
G Paragh, L Asztalos, I Seres, Z Balogh, L Löcsey, I Kárpáti, J Mátyus, ...
Nephron 83 (2), 126-131, 1999
1211999
Induction of NLRP3 inflammasome activation by heme in human endothelial cells
J Erdei, A Tóth, E Balogh, BB Nyakundi, E Bányai, B Ryffel, G Paragh, ...
Oxidative medicine and cellular longevity 2018 (1), 4310816, 2018
1162018
Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: rationale and design of the global EAS …
AJ Vallejo-Vaz, A Akram, SRK Seshasai, D Cole, GF Watts, GK Hovingh, ...
Atherosclerosis Supplements 22, 1-32, 2016
1152016
New insights in synovial angiogenesis
Z Szekanecz, T Besenyei, G Paragh, AE Koch
Joint Bone Spine 77 (1), 13-19, 2010
1112010
Atorvastatin effect on high-density lipoprotein-associated paraoxonase activity and oxidative DNA damage
M Harangi, I Seres, Z Varga, G Emri, Z Szilvássy, G Paragh, É Remenyik
European Journal of Clinical Pharmacology 60, 685-691, 2004
1112004
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–20